Nu Skin Enterprises Inc. (NUS) Financial Statements (2026 and earlier)

Company Profile

Business Address 75 WEST CENTER ST
PROVO, UT 84601
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments239,841252,997265,370213,551197,994237,828
Cash and cash equivalent238,630251,787264,159203,770186,883227,751
Short-term investments1,2111,2101,2119,78111,11110,077
Receivables39,54448,89259,70356,57650,78468,812
Inventory, net of allowances, customer advances and progress billings178,643178,533180,377188,776190,242247,789
Inventory178,643178,533180,377188,776190,242247,789
Prepaid expense 28,308   17,350 
Deferred costs 5,611   6,023 
Derivative instruments and hedges, assets     4,708 
Disposal group, including discontinued operation     26,936 
Deposits current assets 2,122   3,960 
Other current assets 13,114   13,719 
Other undisclosed current assets40,51567,72166,10365,95426,88398,942
Total current assets:547,698548,143571,553524,857538,599653,371
Noncurrent Assets
Operating lease, right-of-use asset74,02179,93377,73679,38972,60585,550
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization377,168375,280374,207380,067379,595410,673
Intangible asset, including goodwill, after accumulated amortization126,239127,823129,562131,179157,903185,151
Goodwill83,62583,62583,62583,62583,62599,885
Intangible asset, excluding goodwill, after accumulated amortization42,61444,19845,93747,55474,27885,266
Disposal group, including discontinued operation, noncurrent assets     22,204 
Other noncurrent assets280,187293,227290,635275,919298,008248,150
Total noncurrent assets:857,615876,263872,140866,554930,315929,524
TOTAL ASSETS:1,405,3131,424,4061,443,6931,391,4111,468,9141,582,895
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities243,734234,437248,906240,300252,688279,351
Accounts payable26,18328,52328,73433,59034,88032,736
Accrued liabilities217,551205,914220,172206,710217,808246,615
Debt20,00020,00035,00020,00030,00060,000
Disposal group, including discontinued operation     13,919 
Total current liabilities:263,734254,437283,906260,300296,607339,351
Noncurrent Liabilities
Long-term debt and lease obligation204,187209,044213,900218,757363,613373,470
Long-term debt, excluding current maturities204,187209,044213,900218,757363,613373,470
Liabilities, other than long-term debt132,152161,130158,133158,385157,239163,199
Disposal group, including discontinued operation, liabilities     1,325 
Other liabilities74,51298,74896,29696,43697,47594,848
Operating lease, liability57,64062,38261,83761,94958,43968,351
Total noncurrent liabilities:336,339370,174372,033377,142520,852536,669
Total liabilities:600,073624,611655,939637,442817,459876,020
Equity
Equity, attributable to parent805,240799,795787,754753,969651,455706,875
Common stock919191919191
Treasury stock, value(1,575,059)(1,565,275)(1,560,411)(1,562,211)(1,563,614)(1,563,878)
Additional paid in capital635,994633,161627,515623,477627,787624,665
Accumulated other comprehensive loss(116,105)(116,916)(114,058)(123,850)(124,758)(105,040)
Retained earnings1,860,3191,848,7341,834,6171,816,4621,711,9491,751,037
Total equity:805,240799,795787,754753,969651,455706,875
TOTAL LIABILITIES AND EQUITY:1,405,3131,424,4061,443,6931,391,4111,468,9141,582,895

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Revenues370,320364,211386,138364,490445,552430,145
Cost of revenue
(Cost of Product and Service Sold)		(108,339)(107,488)(120,405)(117,529)(166,405)(128,682)
Gross profit:261,981256,723265,733246,961279,147301,463
Operating expenses(238,737)(235,081)(234,953)(256,864)(332,228)(283,232)
Operating income (loss):23,24421,64230,780(9,903)(53,081)18,231
Nonoperating income (expense)(1,059)(1,503)(843)(28,375)1,1431,567
Gain (loss), foreign currency transaction, before tax(1,624)  (931)529 
Interest and debt expense(3,994)(4,145)(2,526)(3,283)(26,120)(86)
Income (loss) from continuing operations before equity method investments, income taxes:18,19115,99427,411(41,561)(78,058)19,712
Other undisclosed income (loss) from continuing operations before income taxes    176,16220,256(6,414)
Income (loss) from continuing operations before income taxes:18,19115,99427,411134,601(57,802)13,298
Income tax expense (benefit)(3,700)1,085(6,292)(27,086)21,697(4,996)
Net income (loss) available to common stockholders, diluted:14,49117,07921,119107,515(36,105)8,302

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
Q1
12/31/2025
Q4
9/30/2025
Q3
6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
Net income (loss):14,49117,07921,119107,515(36,105)8,302
Other undisclosed comprehensive income (loss) 2   (406) 
Comprehensive income (loss):14,49317,07921,119107,515(36,511)8,302
Other undisclosed comprehensive income (loss), net of tax, attributable to parent809(2,858)9,792908(19,312)11,955
Comprehensive income (loss), net of tax, attributable to parent:15,30214,22130,911108,423(55,823)20,257

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: